跳至主要内容
临床试验/ACTRN12612001124820
ACTRN12612001124820已完成未知

Topical Platelet Derived Growth Factor (PDGF) Regranex Shows Equivalent Rate of Healing to Placebo for Diabetic Foot Ulcers Off-loaded with Windowed Casts

Heritage Provider Network, Inc0 个研究点目标入组 46 人开始时间: 2012年10月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
Male

入选标准

  • Wagner Grade 1 Diabetic Foot Ulcer, ulcer area between 1-16 square centimerters

排除标准

  • Wagner Grade 2 ulcer or above, osteomyelitis or infection requiring antibiotics, ulcer area outside of range 1-16 square centimeters, more then two full thickness wounds on the involved extremity, moderate to severe peripheral arterial disease (ABI < 0.7), concomitant use of Pletal (cilostazol), inability to tolerate casting or unsteady gait, active neoplasia, concomitant steroid use, chronic alcohol or drug abuse

研究者

发起方
Heritage Provider Network, Inc

相似试验